The Hunter Williams Podcast

P21 | The Brain Peptide Nobody Is Talking About

Jan 27, 2026
A deep dive into a little-known brain peptide called P21 and its origins from CNTF. Discussion of how P21 may boost BDNF, neurogenesis, and synaptic connectivity while lowering neuroinflammation. Reviews animal data on memory, Alzheimer’s models, Down syndrome, and retinal protection. Covers pharmacokinetics, dosing approaches, safety signals, and practical use considerations.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

How P21 Came Onto His Radar

  • Hunter Williams first learned about P21 from parents using intranasal sprays for autistic children and seeing improvements.
  • That led him to research, try it himself, and observe positive effects without heavy nootropic sensations.
INSIGHT

Engineered Neurotrophic Peptide

  • P21 is a synthetic CNTF-derived peptide engineered to cross the blood-brain barrier and remain stable in circulation.
  • It selectively mimics CNTF signaling while avoiding pathways that cause CNTF side effects, favoring neurogenesis and synaptic maintenance.
INSIGHT

Mechanisms: Growth, BDNF, Tau Protection

  • P21 activates JAK-STAT3, MAPK, and PI3K/AKT pathways to support neuron survival and differentiation.
  • It increases BDNF expression and inhibits GSK3-beta phosphorylation, protecting against pathological tau formation.
Get the Snipd Podcast app to discover more snips from this episode
Get the app